000952 Stock Overview
Manufactures and sells pharmaceutical raw materials, medicinal feed additives, fine chemicals, and preparations in China.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Hubei Guangji Pharmaceutical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥5.08 |
| 52 Week High | CN¥8.52 |
| 52 Week Low | CN¥4.11 |
| Beta | 0.014 |
| 11 Month Change | 5.39% |
| 3 Month Change | 0.59% |
| 1 Year Change | -33.77% |
| 33 Year Change | -34.45% |
| 5 Year Change | -33.08% |
| Change since IPO | -11.31% |
Recent News & Updates
Shareholder Returns
| 000952 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | 2.4% | -1.2% | 1.1% |
| 1Y | -33.8% | -18.9% | -20.4% |
Return vs Industry: 000952 underperformed the CN Pharmaceuticals industry which returned -18.9% over the past year.
Return vs Market: 000952 underperformed the CN Market which returned -20.4% over the past year.
Price Volatility
| 000952 volatility | |
|---|---|
| 000952 Average Weekly Movement | 6.2% |
| Pharmaceuticals Industry Average Movement | 5.1% |
| Market Average Movement | 5.4% |
| 10% most volatile stocks in CN Market | 8.5% |
| 10% least volatile stocks in CN Market | 3.6% |
Stable Share Price: 000952 has not had significant price volatility in the past 3 months.
Volatility Over Time: 000952's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1969 | 1,862 | Shu Ruan | www.guangjipharm.com |
Hubei Guangji Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical raw materials, medicinal feed additives, fine chemicals, and preparations in China. The company also exports its products to approximately 30 countries and regions worldwide. Hubei Guangji Pharmaceutical Co., Ltd.
Hubei Guangji Pharmaceutical Co., Ltd. Fundamentals Summary
| 000952 fundamental statistics | |
|---|---|
| Market cap | CN¥1.78b |
| Earnings (TTM) | -CN¥221.09m |
| Revenue (TTM) | CN¥690.36m |
2.6x
P/S Ratio-8.0x
P/E RatioIs 000952 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 000952 income statement (TTM) | |
|---|---|
| Revenue | CN¥690.36m |
| Cost of Revenue | CN¥549.27m |
| Gross Profit | CN¥141.09m |
| Other Expenses | CN¥362.18m |
| Earnings | -CN¥221.09m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.63 |
| Gross Margin | 20.44% |
| Net Profit Margin | -32.03% |
| Debt/Equity Ratio | 94.0% |
How did 000952 perform over the long term?
See historical performance and comparison